PARIS (Reuters) – Sanofi’s SAY.PA The chief in France, Olivier Bogillot, said on Saturday that his future COVID-19 vaccine would be likely to be sold below 10 euros per injection.
“The price is not totally fixed… We are evaluating the production costs for the coming months… We will be below 10 euros,” Bogillot told France Inter radio.
Drugmakers and government agencies around the world are fighting to fight the pandemic and develop vaccines and treatments for COVID-19.
Asked about his rival AstraZeneca AZN.L, which is expected to cost around 2.50 euros in Europe, Bogillot said:
“The price differential for us may be that we are using all of our internal resources, our own researchers, our own research centers. AstraZeneca outsources part of its production ”,
Earlier this week, Sanofi and Britain’s GlaxoSmithKline GSK.L said they had started a clinical trial of their protein-based COVID-19 vaccine candidate and intended to reach the final phase of testing by December.
If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.